Publications

Textbooks:

  1. Vashi NA, Maibach H.  Dermatoanthropology of Ethnic Skin and Hair (first edition).  New York: Springer Science + Business Media LLC, ISBN 978-3-319-53961-4, June, 2017
  2. Vashi NA.  Beauty and Body Dysmorphic Disorder: A Clinician’s Guide (first edition).  New York: Springer Science + Business Media LLC, ISBN 978-3319178660, September, 2015.

Reference Texts:

  1. Vashi NA, Kundu RV.  Congenital and inherited hyperpigmentation disorders. In UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2017.
  2. Vashi NA, Kundu RV.  Approach to the patient with cutaneous hyperpigmentation. In UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2014.

Selected Publications:

  1. Burdine L, Vashi NA. Text-Recycling: Self-Plagiarism in Scientific Writing. Accepted to Int J Womens Dermatol.
  2. Saade DS, Vashi NA. Safe and efficacious treatment ofpurpura with Nd:YAG laser in Skin Types IV­VI. Accepted to J Am Acad Dermatol.
  3. Maymone BC, Rajanala S, Widjajahakim R, Secemsky EA, Saade D, Vashi NA. Willingness to Pay and Time Trade Off: The Burden of Disease in Patients with Benign Hyperpigmentation. Accepted to J Clin Aesthet Dermatol.
  4. Cheng J, Widjajahakim R, Rajanala S, Maymone MBC, Secemsky EA, Vashi NA.Appearance-based versus Health-based Sun-Protective Messages: A Randomized, Double-Blind Controlled Trial. Accepted to J Cosmet Dermatol.
  5. Cheng J, Widjajahakim R, Rajanala S, Maymone MBC, Secemsky EA, Vashi NA. Effect of Stimuli on Sun Protective Habits: A Randomized Double-Blind Controlled Study. Photodermatol Photoimmunol Photomed. 2018 Jul 29 [Epub ahead of print]
  6. Venkatesh S, Maymone MBC, Vashi NA. Aging in Skin of Color. Accepted to Clinics in Dermatology.
  7. Saade DS, de Castro Maymone MB, Vashi NA. The ethics of the cosmetic consult: Performing procedures on the body dysmorphic patient. Int J Womens Dermatol. 2018; 4(3): 185-187.
  8. Maymone MBC, Venkatesh S, Secemsky EA, Reddy K, Vashi NA. Research Techniques Made Simple: Web-based Survey Research in Dermatology: Conduct and Applications. J Invest Dermatol. 2018; 138(7): 1456-1462.
  9. Saade D, Maymone MBC, Kennedy KF, Secemsky EA, Vashi NA. Patterns of Over the Counter Lightening Agent Use among Patients with Hyperpigmentation Disorders: A United States-Based Cohort Study. Accepted to J Clin Aesthet Dermatol.
  10. Vashi NA, Patzelt N, Wirya S, Maymone MBC, Zancanaro P, Kundu RV. Dermatoses secondary to cultural practices. Part II. Cosmetic practices. J Am Acad Dermatol. 2018;79(1): 19-30.
  11. Vashi NA, Patzelt N, Wirya S, Maymone MBC, Kundu RV. Dermatoses secondary to cultural practices. Part I. Therapeutic practices. J Am A cad Dermatol. 2018;79(1 ): 1-16.
  12. Vemula S and Maymone MBC, Secemsky EA, Widjajahakim R, Patzelt NM, Saade D, Vashi NA. Assessing the Safety of Superficial Chemical Peels in Darker Skin: A Retrospective Study. J Am A cad Dermatol. 2018 Mar 5. Epub ahead of print.
  13. Maymone MBC, Neamah HH, Secemsky EA, Vashi NA. Correlating the Dermatology Life Quality Index and Skin Discoloration Impact Evaluation Questionnaire Tools in Disorders of Hyperpigmentation. J Dermatol. 2018;45(3):361-362.
  14. Maymone MBC, Neamah HH, Secemsky EA, Kundu RV, Saade D, Vashi NA. The Most Beautiful People: Evolving Standards of Beauty. JAMA Dermatol. Published online October 11, 2017. doi:10.1001/jamadermatol.2017.3693
  15. Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Secemsky EA, Zancanaro PQ, Vashi NA. The impact of skin hyperpigmentation and hyperchromia on quality of life: A cross-sectional study.  Accepted to J Am Acad Dermatol
  16. Vashi NA, Patzelt N, Wirya S, Maymone MBC, Zancanaro P, Kundu RV. Dermatoses secondary to cultural practices. Part II. Cosmetic practices. Accepted to J Am Acad Dermatol
  17. Vashi NA, Patzelt N, Wirya S, Maymone MBC, Kundu RV. Dermatoses secondary to cultural practices. Part I. Therapeutic practices.  Accepted to J Am Acad Dermatol
  18. Rajanala S, Maymone MBC, Vashi NA. Cleopatra and Sour Milk: The Ancient Practice of Chemical Peeling.  Accepted to JAMA Dermatol.
  19. Vashi NA, Maymone MBC. Dysmorphophobia and The Wolf Man. Accepted to JAMA Dermatol.
  20. Vashi NA, Maymone MBC. An Average Face. Accepted to JAMA Dermatol.
  21. Al-Haseni AG, Maymone MBC, Ho JD, Bhawan J, Vashi NA. Generalized dyschromia and erythematous papules.  Am J Dermatopathol. 2017 Apr 25. [Epub ahead of print]
  22. Wagenseller A, Larocca C, Vashi NA. Treatment of Annular Elastolytic Giant Cell Granuloma with Topical Tretinoin. J Drugs Dermatol. 2017;16(7):699-700.
  23. Vashi NA, Maymone MBC, Kundu RV. Author’s Reply to Cohen: Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment. Am J Clin Dermatol. 2017: 18(4):595-596
  24. Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Secemsky EA, Zancanaro PQ, Vashi NA. Background and Room Illumination in Color Identification of Skin Lesions: A Cross-Sectional Study.  JAMA Dermatol. 2017 May 31. doi: 10.1001/jamadermatol.2017.1016. [Epub ahead of print]
  25. Wirya SA, Maymone MBC, Widjajahakim R, Vashi NA. Subclinical melasma: Determining disease extent.  J Am Acad Dermatol. 2017;77(2):e41-e42.
  26. Maymone M, Neamah HH, Wirya SA, Patzelt NM, Zancanaro PQ, Vashi NA. Sun protective behaviors in patients with cutaneous hyperpigmentation: A cross-sectional study. J Am Acad Dermatol. 2017;76(5):841–846.e2.
  27. Vashi NA, Wirya S, Inyang M, Kundu RV. Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017;18(2):215-230.
  28. Vashi NA. Obsession with perfection: body dysmorphia. Clin Dermatol. 2016;34(6):788-791.
  29. Kouba DJ, LoPiccolo M, Alam M, Bordeaux JS, Cohen B, Hanke CW, Jellinek N, Maibach HI, Tanner JW, Vashi N, Gross KG, Adamson T, Begolka WS, Moyano JV. Guidelines for use of local anesthesia in office-based dermatologic surgery.  J Am Acad Dermatol. 2016;74(6):1201-19.
  30. Vashi NA, Maymone M, Kundu RV. Aging differences in ethnic skin. J Clin Aesthet Dermatol. 2016;9(1):31-38.
  31. Larocca CA, Kundu RV, Vashi NA. Physiologic pigmentation: Molecular mechanisms and clinical diversity. Pigment Int. 2014;1(2):44-51.
  32. Chowdary S, Mahalingam M, Vashi NA. Reading between the layers: early histopathological findings in exogenous ochronosis. Am J Dermatopathol. 2014; 36(12):989-91.
  33. Vashi NA. Cosmetic interventions for dyschromia: lasers.  The Aestheticians Journal. 2014;4(5):16-20.
  34. Vashi NA. Cosmetic interventions for dyschromia: chemical peels.  The Aestheticians Journal.  2014:30-32.
  35. Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment.  Br J Dermatol.  2013;169 Suppl 3:41-56.
  36. Vashi NA, Latkowski JM. The ethics of the medical-pharmaceutical relationship. Clinics in Dermatology. 2012;30(2):188-191.
  37. Vashi NA, Latkowski J. The current state of dermatology training: a national survey of graduating dermatology residents.  J Am Acad Dermatol.  2012;67(6):1384-1386.
  38. Vashi N, Hunt R, Fischer M, Meehan S, Pomeranz MK. Angiofibromas in multiple endocrine neoplasia type 1.  Dermatol Online J. 2012;18(12):20.
  39. Vashi N, Chu J, Patel R. Acquired plate-like osteoma cutis.  Dermatol Online J. Oct 2011;17(10):1.
  40. Vashi N, Newlove T, Chu J, Patel R, Stein J. Graham-Little-Piccardi-Lassueur syndrome.  Dermatol Online J. 2011;17(10):30.
  41. Vashi N, Souza A, Cohen N, Franklin B and Cohen DE. Allergic contact dermatitis to methylphenidate.  Contact Dermatitis.  2011;65(3):183-5.
  42. Vashi N, Mandal R. Giant multi-loculated apocrine hidrocystomas. Dermatol Online J. 2010;16(11):16.
  43. Vashi N, Reddy P, Wayne DB and Sabin B. Bat-associated leptospirosis.  Journal of General Internal Medicine. 2010;25(2):162-4.
  44. Liu JW, Sun P, Yan Q, Paller AS, Gerami P, Ho N, Vashi N, Le Poole IC and Wang XQ. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.  Cancer Res. 2009;69(22):8662-9.
  45. Vashi N.   Annals of Internal Medicine. 2007;147(5):303.

 

Textbook Chapters:

  1. Callaghan D, Vashi NA. Racial and Gender Influences on Skin Disease.  In E. Tur, H. Maibach (Eds.), Gender Dermatology (first edition).  New York: Springer Science + Business Media LLC. In press.
  2. Reddy S, Vashi NA. The Pathophysiology of hyperpigmentation.  In D. Rigopoulos, A.C. Katoulis (Eds.), Hyperpigmentation.  CRC Press.  In press.
  3. Vashi NA, Kundu RV.  Dermatologic Disease in Skin of Color.  In R. Baliga (Ed.), American Board of Internal Medicine Boards (Review Book): Dermatology Section.  In press.
  4. Hahn S, Vashi NA.  The Role of Stress in Body Dysmorphic Disorder.  In K. Franca, M. Jafferany (Eds.), Skin Disorders and Stress: Basic and Clinical Aspects (first edition).  New York: Springer Science + Business Media LLC. ISBN 978-3319463513, December, 2016.
  5. Kundu RV, Vashi NA.  Dermatology in Geriatrics.  In S.C. Taylor, A. P. Kelly, H.W. Lim, A.M. Anido Serrano (Ed.), Dermatology for Skin of Color (second edition).  New York: The McGraw-Hill Education/Medical, ISBN 978-0071805520, January, 2016.
  6. Maymone M, Vashi NA.  Progressive Macular Hypomelanosis. In P. B. Love, R. V. Kundu (Eds.), Clinical Cases in Skin of Color: Adnexal, Inflammation, Infections, and Pigmentary Disorders (first edition).  London: Springer, ISBN 978-3-319-22391-9, November, 2015.
  7. Chang Y, Vashi NA.  Pityriasis Alba.  In P. B. Love, R. V. Kundu (Eds.), Clinical Cases in Skin of Color: Adnexal, Inflammation, Infections, and Pigmentary Disorders (first edition).  London: Springer, ISBN 978-3-319-22391-9, November, 2015.
  8. Reddy S, Vashi NA.  Vitiligo.  In P. B. Love, R. V. Kundu (Eds.), Clinical Cases in Skin of Color: Adnexal, Inflammation, Infections, and Pigmentary Disorders (first edition).  London: Springer, ISBN 978-3-319-22391-9, November, 2015.
  9. Latkowski J, Vashi N.  Mycosis Fungoides Variants. In Hall JC and Hall BJ, eds.  Cutaneous Lymphoma Diagnosis and Treatment: PMPH-USA.  May, 2012.